Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Scientists find evidence of link between coronavirus and neurological disease

For the first time, researchers have found proof of a direct association between strain OC 43 of the human coronavirus (HCoV) and neurological disease in humans.

3 Oct 2016

UEF research shows retinal changes may be detected earlier than brain changes

Diseases of the central nervous system (CNS) may manifest as pathological changes in the retina of the eye.

3 Oct 2016

Abnormal protein in the brain may play important role in development of Alzheimer's disease

A recently-recognized pathologic protein in the brain may play a larger role in the development of clinical Alzheimer's disease dementia than previously recognized, according to a study by researchers at Rush University Medical Center.

30 Sep 2016

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer's disease.

30 Sep 2016

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

The Alzheimer's Drug Discovery Foundation announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna for use as a cancer therapy) in patients with Alzheimer's disease.

29 Sep 2016

Study finds no evidence that exercise may lower woman’s risk of developing MS

A large, new study shows no evidence that exercise may reduce a woman's risk of developing multiple sclerosis (MS).

28 Sep 2016

Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Tau PET is a new and promising imaging method for Alzheimer's disease. A case study from Lund University in Sweden now confirms that tau PET images correspond to a higher degree to actual changes in the brain. According to the researchers behind the study, this increases opportunities for developing effective drugs.

28 Sep 2016

Experimental PET tracer can diagnose concussion-related brain degeneration in living person

An experimental positron emission tomography (PET) tracer can effectively diagnose concussion-related brain degeneration while a person is still alive, according to a proof-of-concept study conducted at the Icahn School of Medicine at Mount Sinai and published September 27 in the journal Translational Psychiatry.

27 Sep 2016

Exercise can increase endocannabinoid levels even under chronic sleep loss

A research group at Uppsala University has investigated how levels of endocannabinoids - which target the same receptors as cannabis - are affected by short sleep duration, and whether acute exercise can modulate this effect.

27 Sep 2016

New study to examine effectiveness of orally administered drug in treating stuttering

Stuttering, an interruption in the flow of speech, affects about three million Americans. It begins most often in childhood, affecting four men for every woman. A precise cause of this complex communicative disorder is not known.

23 Sep 2016

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology.

21 Sep 2016

MR Solutions receives order for cryogen-free 7T simultaneous PET-MR preclinical imaging system

MR Solutions has received an order for a high-powered 7T, cryogen-free, preclinical PET-MRI multi-modality imaging system from the newly formed pre-clinical imaging resource at the Zilkha Neurogenetic Institute (ZNI) at the Keck School of Medicine of the University of Southern California (USC).

21 Sep 2016

Texas A&M research shows nicotine could help protect the aging brain

Everyone knows that tobacco products are bad for your health, and even the new e-cigarettes may have harmful toxins.

21 Sep 2016

SINAPSE network enhances strengths to develop world-class future in medical imaging for Scotland

Scotland has a strong legacy as one of the pioneers of medical imaging. In the late 70s, Aberdeen University became the first institution to develop a full body MRI scanner; the system named the Mark I prototype was an enormous step forward for healthcare.

21 Sep 2016

Stressful event appears to erase benefits linked to healthy fat choices

The type of fat you eat matters, but a new study suggests that the benefits of good fats vanish when stress enters the picture.

20 Sep 2016

CHOP researchers exploit gene discovery in severe epilepsy to identify precision treatment

An international team of researchers who discovered a new gene disorder that causes severe childhood epilepsy leveraged that finding to reduce seizures in two children.

20 Sep 2016

Researchers identify genetic switch that may be potential target for Alzheimer's disease

A team at the MRC Clinical Sciences Centre, based at Imperial College London, has found an important part of the machinery that switches on a gene known to protect against Alzheimer's Disease.

20 Sep 2016

Study of classical Chinese medical literature finds references similar to Alzheimer's disease

A new study of classical Chinese medical texts identifies references to age-related memory impairment similar to modern-day Alzheimer's disease, and to several plant-based ingredients used centuries ago -- and still in use today -- to treat memory impairment.

20 Sep 2016

Researchers reveal presence of toxic protein aggregates in the human brain

The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer's patients.

16 Sep 2016

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances.

15 Sep 2016

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Scientists find evidence of link between coronavirus and neurological disease

UEF research shows retinal changes may be detected earlier than brain changes

Abnormal protein in the brain may play important role in development of Alzheimer's disease

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

Study finds no evidence that exercise may lower woman’s risk of developing MS

Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Experimental PET tracer can diagnose concussion-related brain degeneration in living person

Exercise can increase endocannabinoid levels even under chronic sleep loss

New study to examine effectiveness of orally administered drug in treating stuttering

Experimental drug may prevent development of multiple sclerosis in mice

MR Solutions receives order for cryogen-free 7T simultaneous PET-MR preclinical imaging system

Texas A&M research shows nicotine could help protect the aging brain

SINAPSE network enhances strengths to develop world-class future in medical imaging for Scotland

Stressful event appears to erase benefits linked to healthy fat choices

CHOP researchers exploit gene discovery in severe epilepsy to identify precision treatment

Researchers identify genetic switch that may be potential target for Alzheimer's disease

Study of classical Chinese medical literature finds references similar to Alzheimer's disease

Researchers reveal presence of toxic protein aggregates in the human brain

Food intolerance testing: an interview with Dr Gill Hart

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in